Athira Pharma Inc.

NASDAQ: ATHA · Real-Time Price · USD
0.33
-0.03 (-8.33%)
At close: Jun 09, 2025, 3:59 PM

Athira Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-96.94M -117.67M -95.64M -54.85M
Depreciation & Amortization
455K 969K 845K 479K
Stock-Based Compensation
11.05M 10.62M 10.61M 4.62M
Other Working Capital
-7.86M -840K 9.84M 1.01M
Other Non-Cash Items
n/a -1.2M -219K 493K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-11.98M 6.53M 11.94M 6.16M
Operating Cash Flow
-97.17M -100.75M -72.47M -43.1M
Capital Expenditures
-33K -304K -1.14M -1.57M
Cash Acquisitions
n/a n/a -58.8K 2.51K
Purchase of Investments
-14.13M -27.67M -95.29M -299.2M
Sales Maturities Of Investments
69M 123.06M 154.09M 296.69M
Other Investing Acitivies
n/a n/a 58.8K -2.51K
Investing Cash Flow
54.83M 95.09M 57.66M -4.08M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
194K 493K 654K 327K
Financial Cash Flow
194K 493K 654K 97.09M
Net Cash Flow
-42.15M -5.17M -14.15M 49.91M
Free Cash Flow
-97.2M -101.06M -73.61M -44.67M